COLUMBIA, S.C.–(BUSINESS WIRE)–Colonial Life launches new dental and vision coverage. Dental and vision benefits help maintain and promote overall health.
Author: Business Wire
Castle Biosciences Announces Inclusion of DecisionDx-UM Prognostic Test in New NCCN Guidelines for Uveal Melanoma
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc., today announced that the National Comprehensive Cancer Network (NCCN) has included the DecisionDx®-UM gene expression profile (GEP) test class results in their new clinical practice guidelines for uveal melanoma. These recommendations, released on March 15, 2018, are the first-ever NCCN guidelines for uveal melanoma, and their publication is an important milestone in the care of patients with this rare eye cancer. The new guidelines
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals today reports financial results for the fourth quarter and full year 2017.
North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis 2017-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Minimally Invasive Glaucoma Surgery (MIGS) Devices…
2017-2025 Global Bio-MEMS Market Size, Market Share, Application Analysis, Growth Trends, and Key Players – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Bio-MEMS Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to ResearchAndMarkets.com’s offering….
Ophthalmic Devices Market 2013-2218 & 2024, Global Forecast by Application, Product, Regions and by Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market, Global Forecast by Application by Product, by Regions and by Companies” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmic Device market will be more than US$ 60 Billion by 2024 This report discusses about the Global ophthalmic devices market and further this market is categorized into, namely, Surgical devices, Diagnostic, & Monitoring devices, and Vision care products. This market is mostly powered by a bi
Second Sight Appoints John T. Blake Chief Financial Officer
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vis…
FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis® (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy. In April 2017, Lucentis 0.3 mg became, and remains, the first and only FDA-approved medicine to treat all forms of diabetic retinopathy in people with
Children’s Hospital Los Angeles Treats First Patient on the West Coast Using Gene Therapy
LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles Treats First Patient on the West Coast Using Gene Therapy
CareCloud Named Market Leader in the Spring 2018 Medical Practice Management Software Customer Success Report
MIAMI–(BUSINESS WIRE)–#RCM–Leading business software & services purchasing decision platform recognizes CareCloud as market leader for medical practice software
Global Glaucoma Partnering Directory 2012-2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Partnering 2012 to 2018” report has been added to ResearchAndMarkets.com’s offering. The Global Glaucoma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering dea…
Global Age-related Macular Degeneration Partnering Deals and Agreements 2012-2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Age-related Macular Degeneration Partnering 2012 to 2018” report has been added to ResearchAndMarkets.com’s offering. The Global Age-related Macular Degeneration Partnering Terms and Agreements since 2012 report pro…
The Eye Associates, Clemson Eye and Piedmont Surgery Center Join Eye Health America with Investment from LLR Partners
ATLANTA–(BUSINESS WIRE)–#EyeHealthAmerica–The Eye Associates, Clemson Eye and Piedmont Surgery Center join Eye Health America following investment by LLR Partners. Rod Roeser to serve as CEO.
MEDNAX Announces Acquisition of Pediatric Ophthalmology Practice in Washington
NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2017 and provides a business update. “I’m pleased to announce strong fourth quarter financial performance and full year sales of $18.2 million, which is at the high end of our guidance range,” said Mark M. Sieczkarek, NovaBa
Surgeons at Children’s Hospital Los Angeles Treat the Hospital’s First Patient with Gene Therapy
LOS ANGELES–(BUSINESS WIRE)–Surgeons at Children’s Hospital Los Angeles treat the hospital’s first patient with gene therapy
MellingMedical Awarded Federal Supply Contract for Pharmaceuticals
ALEXANDRIA, Va.–(BUSINESS WIRE)–#Healthcare–MellingMedical, a verified Service Disabled Veteran Owned Small Business (SDVOSB), was recently awarded a federal supply contract for pharmaceuticals.
For Eyes Selects Clutch to Power Better Customer Interactions and More Frequent Purchases
PHILADELPHIA–(BUSINESS WIRE)–#customerdata–Optical retailer For Eyes selects the Clutch Platform to help them capture, analyze and act on every aspect of their customer data.
Aerpio Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 at 3:00 p.m. Eastern Time in New York, NY. Dr. Hoffman will provide a corporate overview and business update. The presentation will be webcast live and may be access
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals announces that it will release fourth quarter and full year 2017 financial results and host a conference call on March 26, 2018.